HealthEquity, Inc. $HQY Shares Sold by One Way Holdings LLC

One Way Holdings LLC trimmed its stake in HealthEquity, Inc. (NASDAQ:HQY) by 6.0% during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 128,873 shares of the company’s stock after selling 8,219 shares during the quarter. One Way Holdings LLC owned approximately 0.16% of HealthEquity worth $11,400,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently modified their holdings of HQY. Vise Technologies Inc. lifted its holdings in shares of HealthEquity by 44.3% during the third quarter. Vise Technologies Inc. now owns 4,922 shares of the company’s stock valued at $435,000 after purchasing an additional 1,510 shares during the last quarter. State of Wyoming raised its holdings in HealthEquity by 4.3% during the 3rd quarter. State of Wyoming now owns 4,350 shares of the company’s stock worth $385,000 after buying an additional 181 shares during the period. VIRGINIA RETIREMENT SYSTEMS ET Al raised its holdings in HealthEquity by 53.8% during the 3rd quarter. VIRGINIA RETIREMENT SYSTEMS ET Al now owns 44,600 shares of the company’s stock worth $3,945,000 after buying an additional 15,600 shares during the period. Moody Aldrich Partners LLC raised its holdings in HealthEquity by 116.8% during the 3rd quarter. Moody Aldrich Partners LLC now owns 48,967 shares of the company’s stock worth $4,332,000 after buying an additional 26,377 shares during the period. Finally, Park Avenue Securities LLC purchased a new stake in HealthEquity during the third quarter valued at about $235,000. 99.55% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other HealthEquity news, Director Adrian Dillon sold 7,632 shares of the company’s stock in a transaction dated Tuesday, August 25th. The shares were sold at an average price of $104.61, for a total transaction of $798,383.52. Following the completion of the sale, the director directly owned 62,395 shares in the company, valued at $6,527,140.95. This represents a 10.90% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 1.60% of the stock is currently owned by corporate insiders.

HealthEquity Stock Performance

HQY opened at $102.47 on Monday. The company has a market cap of $8.48 billion, a PE ratio of 36.99, a price-to-earnings-growth ratio of 1.62 and a beta of 0.22. The stock has a 50-day moving average of $95.37 and a 200-day moving average of $89.04. HealthEquity, Inc. has a 52-week low of $72.76 and a 52-week high of $107.62. The company has a debt-to-equity ratio of 0.47, a quick ratio of 2.99 and a current ratio of 2.99.

HealthEquity (NASDAQ:HQY) last announced its earnings results on Thursday, August 27th. The company reported $1.24 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.19 by $0.05. HealthEquity had a return on equity of 15.33% and a net margin of 17.36%. The firm had revenue of $350.73 million during the quarter, compared to analysts’ expectations of $349.22 million. The business’s revenue was up 95.5% compared to the same quarter last year. HealthEquity has set its FY 2027 guidance at 4.660-4.730 EPS. As a group, equities research analysts forecast that HealthEquity, Inc. will post 3.94 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of research firms have recently issued reports on HQY. Deutsche Bank Aktiengesellschaft boosted their price target on shares of HealthEquity from $135.00 to $142.00 and gave the company a “buy” rating in a report on Monday, August 31st. Wall Street Zen raised shares of HealthEquity from a “hold” rating to a “buy” rating in a research note on Saturday, October 10th. BMO Capital Markets lifted their price objective on shares of HealthEquity from $105.00 to $125.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 21st. Weiss Ratings raised shares of HealthEquity from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Friday, October 16th. Finally, Telsey Advisory Group set a $111.00 price target on HealthEquity in a report on Friday, August 28th. One equities research analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating and one has assigned a Sell rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $113.53.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled benefits administration and financial services that help employers and individuals manage tax-advantaged healthcare accounts. The company’s offerings include health savings accounts (HSAs), flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), and other consumer-directed benefits.

In addition to account administration, HealthEquity provides payment cards, investment options for eligible account holders, employee engagement tools, and digital platforms for managing healthcare benefits.